Bartlett J S, Sethna M, Ramamurthy L, Gowen S A, Samulski R J, Marzluff W F
Gene Therapy Center, University of North Carolina, Chapel Hill 27599, USA.
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8852-7. doi: 10.1073/pnas.93.17.8852.
Few promoters are active at high levels in all cells. Of these, the majority encode structural RNAs transcribed by RNA polymerases I or III and are not accessible for the expression of proteins. An exception are the small nuclear RNAs (snRNAs) transcribed by RNA polymerase II. Although snRNA biosynthesis is unique and thought not to be compatible with synthesis of functional mRNA, we have tested these promoters for their ability to express functional mRNAs. We have used the murine U1a and U1b snRNA gene promoters to express the Escherichia coli lacZ gene and the human alpha-globin gene from either episomal or integrated templates by transfection, or infection into a variety of mammalian cell types. Equivalent expression of beta-galactosidase was obtained from < 250 nucleotides of 5'-flanking sequence containing the complete promoter of either U1 snRNA gene or from the 750-nt cytomegalovirus promoter and enhancer regions. The mRNA was accurately initiated at the U1 start site, efficiently spliced and polyadenylylated, and localized to polyribosomes. Recombinant adenovirus containing the U1b-lacZ chimeric gene transduced and expressed beta-galactosidase efficiently in human 293 cells and airway epithelial cells in culture. Viral vectors containing U1 snRNA promoters may be an attractive alternative to vectors containing viral promoters for persistent high-level expression of therapeutic genes or proteins.
很少有启动子在所有细胞中都高水平活跃。在这些启动子中,大多数编码由RNA聚合酶I或III转录的结构性RNA,无法用于蛋白质表达。RNA聚合酶II转录的小核RNA(snRNA)是个例外。尽管snRNA生物合成独特,且被认为与功能性mRNA的合成不兼容,但我们已测试这些启动子表达功能性mRNA的能力。我们利用小鼠U1a和U1b snRNA基因启动子,通过转染或感染多种哺乳动物细胞类型,从游离型或整合型模板表达大肠杆菌lacZ基因和人α-珠蛋白基因。从包含任一U1 snRNA基因完整启动子的250个核苷酸的5'侧翼序列,或从750个核苷酸的巨细胞病毒启动子和增强子区域,均可获得等量的β-半乳糖苷酶表达。mRNA在U1起始位点准确起始,有效剪接和聚腺苷酸化,并定位于多核糖体。含有U1b-lacZ嵌合基因的重组腺病毒在培养的人293细胞和气道上皮细胞中高效转导并表达β-半乳糖苷酶。对于治疗性基因或蛋白质的持续高水平表达,含有U1 snRNA启动子的病毒载体可能是含有病毒启动子的载体的有吸引力的替代物。